Feline genome probed for future disease studiesFebruary 6, 2024The Morris Animal Foundation-funded research delves into various cat species’ entire DNA, uncovering novel perspectives on domestic and wild cat evolution
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
Lung damage, 'severe' footpad burns among health impacts of bushfires on koalas, study revealsJanuary 9, 2024The new scientific publication, led by a senior lecturer at the University of Adelaide’s School of Animal and Veterinary Sciences, was featured in Veterinary Sciences.
Mentorship program grants students $5,500 stipend for researchDecember 29, 2023The Morris Animal Foundation has announced the acceptance of 24 students to their Veterinary Student Scholar program
More than $86,000 donation from Colorado woman supports animal health researchDecember 19, 2023Michele Alpert had allocated part of her estate to causes aligned with her passion for animals before her passing in January, directing $86,200 to Morris Animal Foundation.
Limb-sparing treatment for canine osteosarcoma to be explored in new studyNovember 14, 2023The new research is set to evaluate the effectiveness of a novel drug combination tailored to giant-breed dogs diagnosed with osteosarcoma.
Controlling tumor growth target of cancer trialAugust 18, 2023 Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway. A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and Virginia Tech, will be funded by the Bernese Mountain Dog Club of America (BMDCA) through Morris Animal Foundation's Donor-Inspired Study program. Histiocytic sarcoma was first described in Bernese mountain dogs in the late 1970s, but has since been noted in many other breeds, Morris Animal Foundation reports. "Histiocytic sarcoma is a devastating disease, and traditional chemotherapeutic drugs have shown limited success in improving treatment outcomes, especially with the disseminated form of the disease," says the study's principal investigator, Vilma Yuzbasiyan-Gurkan, PhD, a professor of microbiology, molecular genetics, and small animal clinical sciences at MSU. "Based on our studies of the molecular pathways driving tumor growth, we now have an opportunity to use a targeted approach in …
Canine cancer study reveals alarming hemangiosarcoma prevalenceAugust 1, 2023Morris Animal Foundation’s Golden Retriever Lifetime Study has now reached a milestone with the accrual of 500 cumulative diagnoses of four major cancers in dogs: hemangiosarcoma, lymphoma, high-grade mast cell tumor, and osteosarcoma.
Canine glaucoma, mitochondria study hopes to thwart blindnessJuly 20, 2023Preventing blindness in dogs is the focus of a newly funded Morris Animal Foundation canine health study.
Immunological disease, reproductive issues more common in purebred catsJune 28, 2023Purebred cats are more likely to experience reproductive issues, heart disease, and surgical complications as compared to mixed-breed felines.
Pet cancer research campaign to match donationsMay 1, 2023Morris Animal Foundation’s annual pet cancer research campaign just received a funding boost, thanks to a dollar-for-dollar pledge from two industry players.
